Eight Advisory supported SERB Pharmaceuticals and Charterhouse Capital Partners on their acquisition of RSDL®
Eight Advisory and Eight Advisory Avocats provided financial and tax due diligence services to SERB Pharmaceuticals and its majority shareholder Charterhouse Capital Partners in the context of their acquisition of RSDL® (Reactive Skin Decontamination Lotion).
Eight Advisory team members supporting on this transaction:
- Financial due diligence: Gennat Mouline (Partner), Julien Roux (Director) and Jean-Baptiste Juszezak (Manager)
Eight Advisory Avocats team members supporting on this transaction:
- Tax due diligence: Guillaume Rembry (Partner-Attorney at law), Guillaume Exerjean (Attorney at law) and Lucie Goeller (Attorney at law)
Deals
Eight Advisory supported Keensight Capital backed Symeres B.V. on the acquisition of DGr Pharma
11 Sep 2025
Read more
Deals
Eight Advisory supported Numeris on the acquisitions of the accounting firms Secab and Compagnie des Comptes
11 Sep 2025
Read more
Deals
Eight Advisory advised Eurazeo on the divestment of its stake in Ultra Premium Direct
11 Sep 2025
Read more
Deals
Eight Advisory Avocats advised Magellan Partners in its entry into exclusive negotiations to acquire the MeTS business from Worldline
9 Sep 2025
Read more